MANHARD KIMBERLY sold 16.7% of their position (1.50K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market sale worth $163.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/15/2026ACC: 0001202094-26-000006
Director
Since May 2024
-1.50K
Net shares
Net seller
$163.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.50K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−500.00
Price / share
$111.78
Trade value
$55.89K
% of position
5.6%
9/11/2026
9K→8.50K
Common Stock
Indirect
Shares
−500.00
Price / share
$110.26
Trade value
$55.13K
% of position
5.9%
9/14/2026
8.50K→8K
Common Stock
Indirect
Shares
−500.00
Price / share
$105.05
Trade value
$52.52K
% of position
6.3%
9/15/2026
8K→7.50K
Total
Net shares
−1.50K
Net value
-$163.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/11/2026 | S · Sale | −500.00 | $111.78 | $55.89K | 5.6% | 9K | 8.50K |
| Common Stock Indirect | 9/14/2026 | S · Sale | −500.00 | $110.26 | $55.13K | 5.9% | 8.50K | 8K |
| Common Stock Indirect | 9/15/2026 | S · Sale | −500.00 | $105.05 | $52.52K | 6.3% | 8K | 7.50K |
| Total | −1.50K | -$163.54K | ||||||
Derivative Transactions0
No derivative transactions reported